Company / Book Value per Share
SELLAS Life Sciences Group, Inc. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.155
FY2024
5-year range
-$0.38 / $5.504
FY2020-FY2024
Trend
+140.7%
vs FY2023
Sector context
#185 of 209
Health Care
What the data says
SELLAS Life Sciences Group, Inc.'s book value per share of $0.155 is lower than 89% of companies in the Health Care sector (FY2024). Book Value per Share returned to growth in FY2024 after 3 years of decline, reaching $0.155.
Based on SEC 10-K filings.
$0.155 in FY2024 with a 5-year CAGR of -42.1%.
Declined from $1.28 to $0.155 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -57.1%
- 5-Year CAGR
- -42.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 209This company $0.155 Sector average $189.406
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -42.1%, indicating a declining trend.
- In FY2024, book value per share increased 140.7% year-over-year.
- Ranks #185 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.155 | +140.7% |
| FY2023 | -$0.38 | -129.7% |
| FY2022 | $1.28 | -34.7% |
| FY2021 | $1.962 | -64.4% |
| FY2020 | $5.504 | +131.1% |
| FY2019 | $2.381 | -88.1% |
| FY2018 | $20.054 | +2167.3% |
| FY2017 | $0.884 | +243.3% |
| FY2016 | -$0.617 | -450.8% |
| FY2015 | -$0.112 | -133.1% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026